Sofia Heigis CEO

Roles

Oncopeptides AB Stockholm
CEO
26.08.202517.03.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
17.03.2026Oncopeptides AB Stockholm
New shares (subscription)
87,833SEK 1.55
SEK 136,141.15
15.09.2025Oncopeptides AB Stockholm
New shares (subscription)
19,312SEK 3.20
SEK 61,798.40
15.09.2025Oncopeptides AB Stockholm
New shares (subscription)
12,626SEK 3.20
SEK 40,403.20
26.08.2025Oncopeptides AB Stockholm
Bought — open marketAcquisition
56,820SEK 4.40
SEK 250,008.00